BioInsights - Eureca-V™ Nuclease: the wild-type MAD7® CRISPR Type-V nuclease licensed from Inscripta®

Eureca-V™ Nuclease: the wild-type MAD7® CRISPR Type-V nuclease licensed from Inscripta®

10.18609/cgti.2022.127

Published: 17 January 2023
Infographic


The Eureca-VTM Nuclease (MAD7®) is a novel Type-V CRISPR nuclease that is particularly well suited to allogeneic cell therapy applications. Here, we chart the development of this important recent addition to the gene editing arsenal.